A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs

References

• Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9:e0003709.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063–2066. doi:10.1016/S0140-6736(12)61899-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO expert consultation on rabies: third report [Internet]. Geneva: World Health Organization; 2018 [cited 2023 Aug 15]. Available from: https://apps.who.int/iris/handle/10665/272364.
   Google Scholar
• Abela-Ridder B. Rabies: 100 per cent fatal, 100 per cent preventable. Vet Rec. 2015;177:148–149. doi:10.1136/vr.h4196
   PubMed Web of Science ®Google Scholar
• El-Sayed A. Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms. Int J Vet Sci Med. 2018;6:8–15. doi:10.1016/j.ijvsm.2018.05.001
   PubMed Web of Science ®Google Scholar
• Müller TF, Schröder R, Wysocki P, et al. Spatio-temporal use of oral rabies vaccines in fox rabies elimination programmes in Europe. PLoS Negl Trop Dis. 2015;9:e0003953. doi:10.1371/journal.pntd.0003953
   PubMed Web of Science ®Google Scholar
• Okolo MI. Vaccine-induced rabies infection in rural dogs in Anambra State, Nigeria. Microbios. 1989;57:105–112.
   PubMedGoogle Scholar
• Hostnik P, Picard-Meyer E, Rihtarič D, et al. Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands. J Wildl Dis. 2014;50:397–401. doi:10.7589/2013-07-183
   PubMed Web of Science ®Google Scholar
• Vuta V, Picard-Meyer E, Robardet E, et al. Vaccine-induced rabies case in a cow (Bos taurus): molecular characterisation of vaccine strain in brain tissue. Vaccine. 2016;34:5021–5025. doi:10.1016/j.vaccine.2016.08.013
   PubMed Web of Science ®Google Scholar
• Maki J, Guiot A-L, Aubert M, et al. Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review. Vet Res. 2017;48:57. doi:10.1186/s13567-017-0459-9
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Blass L, Smith K, et al. Human infection due to recombinant vaccinia–rabies glycoprotein virus. N Engl J Med. 2001;345:582–586. doi:10.1056/NEJMoa010560
   PubMed Web of Science ®Google Scholar
• Human vaccinia infection after contact with a raccoon rabies vaccine bait – Pennsylvania, 2009 [Internet] [cited 2023 Aug 15]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5843a2.htm.
   Google Scholar
• Jenkin D, Ritchie AJ, Aboagye J, et al. Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial. Lancet Microbe. 2022;3:e663–e671. doi:10.1016/S2666-5247(22)00126-4
   PubMedGoogle Scholar
• Kellogg F, Niehus N, DiOrio M, et al. Human contacts with oral rabies vaccine baits distributed for wildlife rabies management – Ohio, 2012. Morb Mortal Wkly Rep. 2013;62:267–269.
   PubMed Web of Science ®Google Scholar
• Hammond J. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine. 2000;18:1040–1050. doi:10.1016/S0264-410X(99)00347-3
   PubMed Web of Science ®Google Scholar
• Bai S, Yang T, Zhu C, et al. A single vaccination of nucleoside-modified rabies mRNA vaccine induces prolonged highly protective immune responses in mice. Front Immunol. 2022;13:1099991. doi:10.3389/fimmu.2022.1099991
   PubMed Web of Science ®Google Scholar
• Schnee M, Vogel AB, Voss D, et al. An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Negl Trop Dis. 2016;10:e0004746. doi:10.1371/journal.pntd.0004746
   PubMed Web of Science ®Google Scholar
• Hellgren F, Cagigi A, Arcoverde Cerveira R, et al. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses. Nat Commun. 2023;14:3713.
   PubMed Web of Science ®Google Scholar
• Mansanguan S, Charunwatthana P, Piyaphanee W, et al. Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents. Trop Med Infect Dis. 2022;7:196. doi:10.3390/tropicalmed7080196
   PubMedGoogle Scholar
• Sinagra G, Merlo M, Porcari A. Exploring the possible link between myocarditis and mRNA COVID-19 vaccines. Eur J Intern Med. 2021;92:28–30. doi:10.1016/j.ejim.2021.08.018
   PubMed Web of Science ®Google Scholar
• Wang B, Xu J, Wu S, et al. Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs. Signal Transduct Target Ther. 2022;7:1–13. doi:10.1038/s41392-021-00710-4
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao Z, Wang Y, et al. Comparative immunogenicity analysis of intradermal versus intramuscular immunization with a recombinant human adenovirus type 5 vaccine against Ebola virus. Front Immunol. 2022;13:963049. doi:10.3389/fimmu.2022.963049
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang Z, Gao H, et al. Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Hum Vaccines Immunother. 2017;13:2078–2085. doi:10.1080/21645515.2017.1342021
   PubMed Web of Science ®Google Scholar
• Tang R, Zheng H, Wang B-S, et al. Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial. Lancet Respir Med. 2023;11:613–623. doi:10.1016/S2213-2600(23)00049-8
   PubMed Web of Science ®Google Scholar
• Zhu F-C, Wurie AH, Hou L-H, et al. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Lond Engl. 2017;389:621–628. doi:10.1016/S0140-6736(16)32617-4
   PubMed Web of Science ®Google Scholar
• Lan W, Quan L, Li Y, et al. Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines. J Virol. 2023;97:e0101423.
   PubMedGoogle Scholar
• Liu W, Li H, Liu B, et al. A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine. Emerg Microbes Infect. 2023;12:2233643. doi:10.1080/22221751.2023.2233643
   PubMed Web of Science ®Google Scholar
• Napolitano F, Merone R, Abbate A, et al. A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C. PLoS Negl Trop Dis. 2020;14:e0008459. doi:10.1371/journal.pntd.0008459
   PubMed Web of Science ®Google Scholar
• Kilgore PB, Sha J, Andersson JA, et al. A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform. NPJ Vaccines. 2021;6:1–13. doi:10.1038/s41541-020-00275-3
   PubMed Web of Science ®Google Scholar
• Zhang C, Tian Y, Chen C, et al. Virus-like vesicles based on Semliki forest virus-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model. J Virol. 2021;95:e0079021.
   PubMed Web of Science ®Google Scholar
• Schnell MJ, Mebatsion T, Conzelmann KK. Infectious rabies viruses from cloned cDNA. EMBO J. 1994;13:4195–4203. doi:10.1002/j.1460-2075.1994.tb06739.x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu Q, Zhou M, et al. Composition of the murine gut microbiome impacts humoral immunity induced by rabies vaccines. Clin Transl Med. 2020;10:e161. doi:10.1002/ctm2.161
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang Y, Chen Y, et al. A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model. Emerg Microbes Infect. 2021;10:913–928. doi:10.1080/22221751.2021.1923341
   PubMed Web of Science ®Google Scholar
• Wang Z, Yuan Y, Chen C, et al. Colloidal manganese salt improves the efficacy of rabies vaccines in mice, cats, and dogs. J Virol. 2021;95:e0141421.
   PubMed Web of Science ®Google Scholar
• Shin C, Han J-A, Koh H, et al. CD8α− dendritic cells induce antigen-specific T follicular helper cells generating efficient humoral immune responses. Cell Rep. 2015;11:1929–1940. doi:10.1016/j.celrep.2015.05.042
   PubMed Web of Science ®Google Scholar
• Kawamura K, Iyonaga K, Ichiyasu H, et al. Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin Diagn Lab Immunol. 2005;12:206–212.
   PubMedGoogle Scholar
• Pelissier A, Stratigopoulou M, Donner N, et al. Convergent evolution and B-cell recirculation in germinal centers in a human lymph node. Life Sci Alliance. 2023;6:e202301959. doi:10.26508/lsa.202301959
   PubMed Web of Science ®Google Scholar
• Tolentino Júnior DS, Marques MSV, Krummenauer A, et al. Rabies outbreak in Brazil: first case series in children from an indigenous village. Infect Dis Poverty. 2023;12:78. doi:10.1186/s40249-023-01130-y
   PubMed Web of Science ®Google Scholar
• Ji C, Feng J, Li S, et al. Factors associated with dog rabies immunization in Changsha, China: results of a cross-sectional cluster survey, 2015–2021. Viruses. 2022;15:138. doi:10.3390/v15010138
   PubMed Web of Science ®Google Scholar
• Khan UR, Soomar SM, Ghazi SM, et al. Epidemiological pattern and management of dog bite injuries in Karachi, Pakistan: a cross-sectional study. Injury. 2023;54(Suppl 4):110473. doi:10.1016/j.injury.2022.11.016
   PubMedGoogle Scholar
• Molinier-Frenkel V, Lengagne R, Gaden F, et al. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol. 2002;76:127–135. doi:10.1128/JVI.76.1.127-135.2002
   PubMed Web of Science ®Google Scholar
• Sallard E, Schulte L, van den Boom A, et al. Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5. J Gene Med. 2023:e3576. doi:10.1002/jgm.3576
   PubMed Web of Science ®Google Scholar
• Wang H, Georgakopoulou A, Zhang W, et al. HDAd6/35++ – a new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells. Mol Ther Methods Clin Dev. 2023;29:213–226. doi:10.1016/j.omtm.2023.03.008
   PubMed Web of Science ®Google Scholar
• Cohen CJ, Xiang ZQ, Gao G-P, et al. Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor. J Gen Virol. 2002;83:151–155. doi:10.1099/0022-1317-83-1-151
   PubMed Web of Science ®Google Scholar
• Zou P, Zhang P, Deng Q, et al. Two novel adenovirus vectors mediated differential antibody responses via interferon-α and natural killer cells. Microbiol Spectr. 2023;11:e00880-23.
   PubMed Web of Science ®Google Scholar
• King CR, Zhang A, Tessier TM, et al. Hacking the cell: network intrusion and exploitation by adenovirus E1A. mBio. 2018;9:10-1128. doi:10.1128/mbio.00390-18
   Web of Science ®Google Scholar
• Yan L, Zhao Z, Xue X, et al. A bivalent human adenovirus type 5 vaccine expressing the rabies virus glycoprotein and canine distemper virus hemagglutinin protein confers protective immunity in mice and foxes. Front Microbiol. 2020;11:1070. doi:10.3389/fmicb.2020.01070
   PubMed Web of Science ®Google Scholar
• Tan Y, Liang H, Chen A, et al. Coexpression of double or triple copies of the rabies virus glycoprotein gene using a ‘self-cleaving’ 2A peptide-based replication-defective human adenovirus serotype 5 vector. Biol J Int Assoc Biol Stand. 2010;38:586–593.
   Google Scholar
• Schaack J. Adenovirus vectors deleted for genes essential for viral DNA replication. Front Biosci J Virtual Libr. 2005;10:1146–1155. doi:10.2741/1607
   PubMed Web of Science ®Google Scholar
• Prevec L, Schneider M, Rosenthal KL, et al. Use of human adenovirus-based vectors for antigen expression in animals. J Gen Virol. 1989;70(Pt 2):429–434. doi:10.1099/0022-1317-70-2-429
   PubMed Web of Science ®Google Scholar
• Mudrick HE, Massey S, McGlinch EB, et al. Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Sci Adv. 2022;8:eabm8563. doi:10.1126/sciadv.abm8563
   PubMed Web of Science ®Google Scholar
• Blair GE, Dixon1 SC, Griffiths SA, et al. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res. 1989;14:339–346. doi:10.1016/0168-1702(89)90026-9
   PubMed Web of Science ®Google Scholar
• Tatsis N, Fitzgerald JC, Reyes-Sandoval A, et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 2007;110:1916–1923. doi:10.1182/blood-2007-02-062117
   PubMed Web of Science ®Google Scholar
• Sheets RL, Stein J, Bailer RT, et al. Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer’s construct, or gene inserts. J Immunotoxicol. 2008;5:315–335. doi:10.1080/15376510802312464
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang Y, Huang Y, et al. The ectodomain of rabies virus glycoprotein determines dendritic cell activation. Antiviral Res. 2017;141:1–6. doi:10.1016/j.antiviral.2017.01.022
   PubMed Web of Science ®Google Scholar
• Shi C, Tian L, Zheng W, et al. Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a rabies virus G protein confers long-lasting immune responses in mice and non-human primates. Emerg Microbes Infect. 2022;11:1439–1451. doi:10.1080/22221751.2022.2078226
   PubMed Web of Science ®Google Scholar
• Hooper DC, Roy A, Barkhouse DA, et al. Rabies virus clearance from the central nervous system. Adv Virus Res. 2011;79:55–71. doi:10.1016/B978-0-12-387040-7.00004-4
   PubMed Web of Science ®Google Scholar
• Cenna J, Tan GS, Papaneri AB, et al. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Vaccine. 2008;26:6405–6414. doi:10.1016/j.vaccine.2008.08.069
   PubMed Web of Science ®Google Scholar
• Klimovich VB. Igm and its receptors: structural and functional aspects. Biochem Biokhimiia. 2011;76:534–549. doi:10.1134/S0006297911050038
   PubMed Web of Science ®Google Scholar
• Flamand A, Raux H, Gaudin Y, et al. Mechanisms of rabies virus neutralization. Virology. 1993;194:302–313. doi:10.1006/viro.1993.1261
   PubMed Web of Science ®Google Scholar